Anchyra Partners LLC Merck & Co., Inc. Transaction History
Anchyra Partners LLC
- $326 Billion
- Q4 2025
A detailed history of Anchyra Partners LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Anchyra Partners LLC holds 8,807 shares of MRK stock, worth $817,818. This represents 0.28% of its overall portfolio holdings.
Number of Shares
8,807Holding current value
$817,818% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,968Shares Held
1.9BCall Options Held
29.9MPut Options Held
27.3M-
Vanguard Group Inc Valley Forge, PA254MShares$23.6 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...